Drug and Medication Analysis & Statistics in Europe Countries, October 2014

You might be interested in: drug, vaccine, smoking cessation, more »

1-50 of about 1 500 reports

Purchase Reports From Reputable Market Research Publishers

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: In terms of its attractiveness to investors, Slovenia remains a mid-tier pharmaceutical industry within Emerging Europe. While not immune from economic factors and government austerity drives, ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Austria Pharmaceuticals and Healthcare Report Q4 2014

Austria Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of ...

  • Industries : Drug and Medication
  • Countries : Austria
Poland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Poland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: Late-stage revisions to Poland's pharmaceutical reimbursement act have been broadly positive for pharmaceutical industry players operating in this industry . However, the central premise of the ...

  • Industries : Drug and Medication
  • Countries : Poland
Romania Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Romania Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We continue to expect Romania's pharmaceutical industry to return to high single-digit growth in 2011 and 2012. However, weaker than expected drug price inflation in Q211 has resulted in a downward ...

  • Industries : Drug and Medication
  • Countries : Romania
France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: France is one of the leading global pharmaceutical industry s by size, propped up by its large population of just under 63mn. The French are traditionally fond of patented and branded drugs and ...

  • Industries : Drug and Medication
  • Countries : France
Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: Despite the threat of austerity measures, the government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result of the ...

  • Industries : Drug and Medication
  • Countries : Germany
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We continue to project that the Széll Kálmán structural reforms plan, which aims to achieve savings of HUF120bn (US Dollar 580mn) over three years from Hungary’s medicine budget will lead ...

  • Industries : Drug and Medication
  • Countries : Hungary
Italy Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Italy Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We believe the Italian government's decision to implement further austerity measures is a necessary and prudent course of action – Italy maintains one of the largest sovereign debt loads in ...

  • Industries : Drug and Medication
  • Countries : Italy
Sweden Pharmaceuticals and Healthcare Report Q4 2014

Sweden Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: As Sweden's population grows older and demands for healthcare provision increase, the government is facing a concerning scenario of rapidly increasing expenditure ...

  • Industries : Drug and Medication
  • Countries : Sweden
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Latvia's disease profile and relatively low per-capita consumption of pharmaceuticals (compared with the rest of developed Europe) is a clear illustration of the need for innovative medicines. ...

  • Industries : Drug and Medication
  • Countries : Latvia
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: In response to the expected passage of key drug policy reforms in the Czech Republic, BMI has cut its projections for pharmaceutical industry growth in 2012 to 0.0%, with the prospects of lowe ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Our view that Greece's pharmaceutical industry is set for a decade of decline remains firmly in play. The list of challenges is sizeable: the combination of price erosion mechanisms; rapid generic ...

  • Industries : Drug and Medication
  • Countries : Greece
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The short-term outlook for the Serbian pharmaceutical industry will continue to be clouded by corruption, debts accrued by the country’s health insurance ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Full-year trade data for 2011 and Q112 has confirmed that Moldova’s pharmaceutical industry has returned to more normal growth. However, with regional economic ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: We believe the pharmaceuticals and healthcare segment may be targeted by the government's 2011 cost-containment efforts following the successful implementation of austerity measures in 2010. ...

  • Industries : Drug and Medication
  • Countries : Spain
Russia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Russian pharmaceutical industry retains vast growth potential and the short- term environment is very positive for both domestic and foreign drugmakers. ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

BMI View: The UK faces its most uncertain period in a generation, as the Conservative-Liberal Democrat coalition presses ahead with fiscal cutbacks and constitutional reform. Plans to modernise the National ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Finland Pharmaceuticals and Healthcare Report Q3 2014

Finland Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Innovative drugmaker revenues will remain under threat in Finland. The Finnish government is committed to containing rising healthcare costs and despite company ...

  • Industries : Drug and Medication
  • Countries : Finland
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The period 2011-16 is projection to witness the proliferation of government initiatives supporting the growth of Switzerland's generic medicines industry, which ...

  • Industries : Drug and Medication
  • Countries : Switzerland
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

BMI View: The pharmaceutical industry in Belarus has significant long-term growth potential, but the country’s economy has entered a period of acute crisis and its long-deferred day of reckoning may ...

  • Industries : Drug and Medication
  • Countries : Belarus
Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Ukraine remains one of Central and Eastern Europe’s promising pharmaceutical industries, but its chronic lack of economic and political stability remains ...

  • Industries : Drug and Medication
  • Countries : Ukraine
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Our view that Slovenia’s drug industry is one of the most stable in the region remains in place despite the fact that - at the start of 2012 - the government ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Poland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Poland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Despite numerous challenges, we continue to believe Poland is the most attractive pharmaceutical industry in Central and Eastern Europe (CEE). While the long-awaited ...

  • Industries : Drug and Medication
  • Countries : Poland
Romania Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Although the fall of Romania’s government in a no-confidence vote in late April was a surprise, apart from changes in risk sentiment negatively affecting ...

  • Industries : Drug and Medication
  • Countries : Romania
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the recently appointed new heads at the Bulgarian Ministry of Health and the National Health Insurance Fund (NHIF) are now clearly looking at more aggressive ...

  • Industries : Drug and Medication
  • Countries : Bulgaria
Austria Pharmaceuticals and Healthcare Report Q3 2014

Austria Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Austria's economy is set to grow at a faster clip in the second half of 2014 and domestic consumer demand is poised to strengthen in this period. We have revised ...

  • Industries : Drug and Medication
  • Countries : Austria
Germany Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Germany Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the increased consumption of generic medicines will have an impact on the overall pharmaceutical industry projection for Germany, we note that government ...

  • Industries : Drug and Medication
  • Countries : Germany
Italy Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We projection deteriorating prospects for drugmakers in Italy because in addition to a decline in public spending on pharmaceuticals (enforced by price cuts ...

  • Industries : Drug and Medication
  • Countries : Italy
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals ...

  • Industries : Drug and Medication
  • Countries : Netherlands
About 2 500 reports

Download Unlimited Documents from Trusted Public Sources

Antibiotic market structure in the UK

  • September 2014
    13 pages
  • Antibiotic  

  • United Kingdom  

View report >

2 Companies

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.